Cisa home laiv study- lead site, EO 14398
Active Awarded
- Contract number
- 75D30126F00004
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,869,870
Award facts
- Opportunity
-
- 75D30126R73525 Solicitation number
- Contract value 99% obligated
-
- $1,869,870.00 Current, with exercised options
- $1,887,319.00 Potential, with all options
- Completion date 2% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
CDC Pittsburgh issued a delivery order to Duke University on September 25, 2026, under the Clinical Immunization Safety Assessment 2023–2028 (CISA) IDIQ with a ceiling value of $1,887,319, for the CISA HOME LAIV Study lead site in support of Executive Order 14398.
CISA is a CDC-managed indefinite delivery contract vehicle for clinical immunization safety assessment services. Place of performance is Durham, NC 27705. The order runs through September 27, 2029, on a time and materials pricing basis. Work encompasses execution of the HOME LAIV (Live Attenuated Influenza Vaccine) study as the lead site, supporting CDC's immunization safety monitoring and research mission.
Quick answers
Who was awarded contract 75D30126F00004?
75D30126F00004 was awarded to Duke University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 25, 2026.
How much is contract 75D30126F00004 worth?
The government has obligated $1,869,870 on 75D30126F00004. Its potential value, with all options, is $1,887,319.
Is contract 75D30126F00004 an order under another contract?
Yes. 75D30126F00004 is a delivery order under 75D30123D18241, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).
Was contract 75D30126F00004 competed?
The extent of competition for 75D30126F00004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award